Discovery On Target 2023

Paid

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative prese

25-28 September 2023

Healthcare

GPCR-Based Drug Discovery

Paid

Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated by biopharmaceutical drugs. The cell surface location of GPCRs enables modulation by a variety of mo

26-27 September 2023

Healthcare

Small Molecules for Cancer Targets – Part 1

Paid

Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules offer the promise of medicine in pill form and more affordability than do biologics, but they also

26-27 September 2023

Healthcare

Genomics-Driven Drug Discovery

Paid

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s conference on Genomics-Driven Drug Discovery discusses the use of functional genomics screening, gene

27-28 September 2023

Healthcare

Lead Generation Strategies

Paid

Cambridge Healthtech Institute’s annual Lead Generation Strategies conference illuminates the latest approaches used by medicinal, biophysical and computational chemists to discover and develop small molecules (and now slightly larger molecules that retain potential for oral bioavailability) into drug candidates. Join us to hear case studies applyi

27-28 September 2023

Healthcare

Antibodies Against Membrane Protein Targets – Part 2

Paid

As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an alternative for targets with known function that have not been amenable to small molecule drugs and the po

27-28 September 2023

Healthcare

Fibrosis and Inflammation

Paid

Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in t

27-28 September 2023

Healthcare

Targeting Transcription Factors

Paid

Transcription factors are proteins with DNA-binding domains that are involved in gene transcription. They are key cell regulators and alterations in their structure, binding, or activity are often found associated with many abnormalities in cellular function and in disease. Transcription factors have been targeted in different ways, by modulating t

27-28 September 2023

Healthcare

AI/ML-Enabled Drug Discovery – Part 2

Paid

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying novel drug targets, drug design, virtual screening, lead optimization, and ADME/toxicology assessments.

27-28 September 2023

Healthcare